Fezolinetant (Veoza)
Moderate to Severe Vasomotor Symptoms due to Menopause
Key Facts
Indication
Moderate to Severe Vasomotor Symptoms due to Menopause
Phase
Phase III / Filed
Status
Active (Launched)
Company
About Richter Gedeon
Richter Gedeon's mission is to improve patient lives through the research, development, and global commercialization of innovative pharmaceuticals. The company has achieved a dominant position in its core Central and Eastern European markets while expanding its international footprint, supported by a robust pipeline of 34 candidates. Its strategy is built on deep therapeutic expertise in women's health and CNS, vertical integration from API to finished product, and a disciplined approach to both organic R&D and strategic partnerships to fuel sustainable growth.
View full company profile